ArticleCanadian prosthetics & orthotics journal2021
Editor's Perspective on Health Economics in Prosthetics and Orthotics.
Article in Canadian prosthetics & orthotics journal, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
There is a scarcity of literature exploring Health Economics in Prosthetics and Orthotics (P&O). The P&O sector has, over the past decades, moved to a Bachelor's or Masters Degree level as the requirement for entry to practice and, with that, there has been a growing body of research and knowledge generation focusing primarily on clinical aspects and engineering advances. No corresponding body of research has emerged on the economic aspects of P&O, creating a fundamental weakness in both technical and clinical research efforts to advance this field within an economically sustainable framework. This weakness will become critical as data driven engineering advances (e.g. exoskeletons, mass customizable prostheses) and clinical improvements (e.g. osseointegration, diabetes treatments) will make reimbursement for devices ever more complex and challenging. The tension between what is possible and what is fundable will increase unless what is possible also drives down costs. Finding the right balance in Prosthetics and Orthotics will be a challenge, as this sector already struggles to justify current standards of care. This Special Edition takes a snapshot of stakeholder perspectives and opinions on the topic of Health Economics in P&O and is organized around the following stakeholder groups: End-user, Researcher (Engineering and Clinical), Prosthetic and Orthotic Practitioner and, of critical importance, four papers describing an interdisciplinary project on the Health Economics of Osseointegration that was led by a payor. Each author was also asked to provide a "Call to Action" in which they identify one or more key areas that need to be addressed in order to move forward with the barriers or opportunities they have identified in their paper. The intent of the Special Edition is to generate discussion and encourage more in-depth research on this topic.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.